A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2
מצבים רפואיים
Prostate Cancer Patients Treated by Radiotherapy · Prostate Cancer (Adenocarcinoma)
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Academic Urology and Urogynecology of Arizona, Peoria, Arizona, United States
Contact: Principal Investigator (Chandan Kundavaram, M.D.)Colorado Clinical Research, Lakewood, Colorado, United States
Contact: Study coordinator (Stephanie Melgar-Donis) · Stephanie.melgar-donis@coloradouro.com · 720-213-3130Contact: Principal Investigator (Thomas Facelle, M.D.)Urology Associates, Littleton, Colorado, United States
Contact: Principal Investigator (James Fagelson, M.D.)Chesapeake Urology Research Associates, Towson, Maryland, United States
Contact: Principal Investigator (Ronald Tutrone, M.D.)Sheldon Freedman, MD Ltd., Las Vegas, Nevada, United States
Contact: Principal Investigator (Sheldon Freedman, M.D.)Summit Health, Saddle Brook, New Jersey, United States
Contact: Study coordinator (Michelle Mackenzie, RN OCN CCRC) · Mmackenzie@summithealth.com · 973-436-1755Contact: Principal Investigator (Glen Gejerman, M.D.)START Carolinas, Myrtle Beach, South Carolina, United States
Contact: Study coordinator (Taylor Stephenson) · taylor.stephenson@startresearch.com · (843) 839-1679Contact: Principal Investigator (John Sylvester, M.D.)